RCMI Coordinating Center (RCMI CC) Header Logo

Connection

James Lillard to Cystadenocarcinoma, Serous

Back to Details
This is a "connection" page, showing publications James Lillard has written about Cystadenocarcinoma, Serous.
James Lillard
Connection Strength
0.221
Cystadenocarcinoma, Serous
  1. Carey KM, Young CD, Clark AJ, Dammer EB, Singh R, Lillard JW. Subtype-specific analysis of gene co-expression networks and immune cell profiling reveals high grade serous ovarian cancer subtype linkage to variable immune microenvironment. J Ovarian Res. 2024 Dec 03; 17(1):240.
    View in: PubMed
    Score: 0.221
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support